Switch to:
GuruFocus has detected 2 Warning Signs with NovaBay Pharmaceuticals Inc $NBY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
NovaBay Pharmaceuticals Inc (AMEX:NBY)
Additional Paid-In Capital
$111.89 Mil (As of Mar. 2017)

NovaBay Pharmaceuticals Inc's quarterly additional paid-in capital increased from Sep. 2016 ($108.59 Mil) to Dec. 2016 ($110.62 Mil) and increased from Dec. 2016 ($110.62 Mil) to Mar. 2017 ($111.89 Mil).

NovaBay Pharmaceuticals Inc's annual additional paid-in capital increased from Dec. 2014 ($73.37 Mil) to Dec. 2015 ($85.39 Mil) and increased from Dec. 2015 ($85.39 Mil) to Dec. 2016 ($110.62 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

NovaBay Pharmaceuticals Inc Annual Data

AdditionalPaidInCapital 32.5933.7237.0038.4742.3954.0064.4473.3785.39110.62

NovaBay Pharmaceuticals Inc Quarterly Data

AdditionalPaidInCapital 73.3777.7385.2485.8085.3988.2595.73108.59110.62111.89
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat